Skip to main content

Rotator Cuff Tear Arthropathy

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Arthrex
ArthrexCA - Santa Barbara
2 programs
Repair of the subscapularisN/A1 trial
Universe Reverse ProsthesisN/A1 trial
Active Trials
NCT05438914Unknown134Est. Sep 2025
NCT01778777Completed166Est. Apr 2023
Zimmer Biomet
Zimmer BiometFL - Jacksonville
1 program
COMPREHENSIVEN/A1 trial
Active Trials
NCT02084693Completed100Est. Jun 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ArthrexRepair of the subscapularis
Zimmer BiometCOMPREHENSIVE
ArthrexUniverse Reverse Prosthesis

Clinical Trials (3)

Total enrollment: 400 patients across 3 trials

NCT05438914ArthrexRepair of the subscapularis

Subscapularis Repair in Reverse Shoulder Arthroplasty

Start: Nov 2022Est. completion: Sep 2025134 patients
N/AUnknown

COMPREHENSIVE® REVERSE SHOULDER Mini BasePlate

Start: Dec 2013Est. completion: Jun 2019100 patients
N/ACompleted
NCT01778777ArthrexUniverse Reverse Prosthesis

Safety Study of Univers® Revers Shoulder Prosthesis

Start: Sep 2013Est. completion: Apr 2023166 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.